Liminal BioSciences Reports Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Liminal BioSciences (LMNL) Reports Q3 Revenues of $600K
November 12, 2020 5:14 PM ESTLiminal BioSciences (NASDAQ: LMNL) reported Q3 revenue for the quarter came in at $600 thousand, versus $800 thousand reported last year.
Third Quarter Financial Results:
Following the sale of our bioseparations business segment in the fourth quarter of 2019, we have restated the prior periods to remove the impact of those operations from the lines in the financial statements and have reclassified those results to the discontinued operations line in the financial statements. All amounts presented in this section are in C$ unless otherwise specified.
Cash Position: Cash and cash equivalents at September 30, 2020 were... More